论文部分内容阅读
目的:探讨甲磺酸加替沙星治疗泌尿系感染的临床疗效和安全性。方法:选择68例泌尿系感染患者,随机分成观察组(34例)和对照组(34例),治疗组给予甲磺酸加替沙星注射液静脉滴注,对照组给予环丙沙星治疗。结果:观察组和对照组总有效率分别为88.2%和85.2%,不良反应发生率分别为8.36%和8.72%,差异均无显著意义(P>0.05)。结论:甲磺酸加替沙星治疗细菌性泌尿系感染安全、有效。
Objective: To investigate the clinical efficacy and safety of gatifloxacin mesylate in the treatment of urinary tract infection. Methods: Sixty-eight patients with urinary tract infection were selected and randomly divided into observation group (34 cases) and control group (34 cases). The treatment group received intravenous infusion of gatifloxacin mesylate injection and the control group received ciprofloxacin . Results: The total effective rate in observation group and control group was 88.2% and 85.2%, respectively, and the incidence of adverse reactions were 8.36% and 8.72% respectively, with no significant difference (P> 0.05). Conclusion: Gatifloxacin mesylate is safe and effective in the treatment of bacterial urinary tract infection.